Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder.

Francescone SA, Murphy B, Fallon JT, Hammond K, Pinney S. Tumor lysis syndrome occurring after the administration of rituximab for posttransplant lymphoproliferative disorder. Transplant Proc. 2009 Jun; 41(5):1946-8.

View in: PubMed

collapse authors with profiles